NCT05531903

Brief Summary

Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common supraventricular tachycardia inducible during an electrophysiological study. Although ablative therapy proved to be the treatment of choice, little is known about the components of the tachycardia circuit. The aim of this study is to detect the presence and patterns of specific electrograms representing slow pathway (SP) potentials and to explore Koch's triangle pattern activation during sinus rhythm and/or atrial extraestimulus with a high-density mapping catheter in an attempt to clarify a fast and safety catheter ablation strategy. We hypothesized that, in patients with dual atrioventricular nodal physiology, during sinus rhythm (SR), high-density mapping (HDM) catheters could identify the SP signals, making possible to delineate small areas of slow conduction associated to abnormal electrograms on Koch's triangle. On a second step, radiofrequency (RF) applications safety guided by the HDM obtained with this method, should interrupt the circuit far from the His region. Finally, SP signals should disappear after the RF procedure when performing a new 3D HDM. A control group of patients without AVN dual physiology should show absence of fragmented/slow conduction zones.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
119

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 8, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

October 15, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

April 12, 2024

Status Verified

April 1, 2024

Enrollment Period

10 months

First QC Date

August 28, 2022

Last Update Submit

April 10, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Absence of reinduction of AVNRT after abolition of fragmented/slow conduction signals

    Number of patients with absence of fragmented/slow conduction signals observed during sinus rhythm or atrial pacing after radiofrequency application

    one day

Secondary Outcomes (2)

  • Absence of AVNRT relapses

    one month

  • Percentage of patient without AVNRT reinduction after procedure

    One day

Study Arms (1)

Patients with atrioventricular node reentrant tachycardia

EXPERIMENTAL

Patient with documented AVNRT and fragmented/slow conduction zones observed in a 3D high density mapping

Device: Description of Slow pathway signals to facilitate ablation

Interventions

3D endocardial mapping in order to identify slow pathway signals and abolish or modificate them after radiofrequency ablation

Patients with atrioventricular node reentrant tachycardia

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients \> 18 yo with AVNRT observed after electrophysiological study

You may not qualify if:

  • Patients \< 18 yo

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jesús Ignacio Jiménez López

Barcelona, 08005, Spain

Location

MeSH Terms

Conditions

Tachycardia, SupraventricularTachycardia, Atrioventricular Nodal Reentry

Condition Hierarchy (Ancestors)

TachycardiaArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesCardiac Conduction System DiseasePathologic ProcessesPathological Conditions, Signs and SymptomsTachycardia, Reciprocating

Study Officials

  • Jesús Ignacio Jimenez López, MD

    Parc de Salut Mar

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single group of intervention. A control group with absence of dual AVN phisiology to check lack of abnormal fragmented/slow conduction confluent zones.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 28, 2022

First Posted

September 8, 2022

Study Start

October 15, 2022

Primary Completion

July 30, 2023

Study Completion

September 1, 2023

Last Updated

April 12, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Data will be register with RED CAP

Locations